Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Affibody and Nuclisome join forces to develop cancer therapeutics

Dec. 23, 2011

GlaxoSmithKline presents novel protein kinase inhibitors

Dec. 23, 2011

Merck & Co. discloses new B-raf inhibitors

Dec. 23, 2011

VANTAGE 88 reveals activity of combination therapy for multiple myeloma

Dec. 23, 2011

Hande Starlake Bioscience prepares new PARP inhibitors

Dec. 22, 2011

Novel epidermal growth factor receptor inhibitors synthesized by Chinese university

Dec. 22, 2011

NewGen Therapeutics acquires targeted oncology programs

Dec. 22, 2011

Hanmi and Kinex sign Orascovery licensing agreement

Dec. 22, 2011

Roche's Zelboraf receives CHMP opinion

Dec. 21, 2011

Scientists at AstraZeneca present new therapy for AML

Dec. 21, 2011

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...